CCND2 and breast cancer: In our gene‐specific promoter methylation analysis, we observed elevated odds of BC for hypomethylated CCND2 promoter methylation for MPB (highest vs. lowest quantiles) and lower odds for hypermethylated CCND2 promoter methylation‐defined BC for BPB (highest vs. lowest quantile).